Completed NA INTERVENTIONAL 1-arm NCT00909441

Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC)

Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer: A Multi-institutional Prospective Study Furthering the Treatment of Breast Cancer

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Conditions Breast Cancer Invasive Breast Cancer

Interventions Sentinel Lymph Node Biopsy

Updated 7 times since 2017 Last updated: Feb 9, 2015 Started: Feb 28, 2009 Primary completion: Feb 29, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Invasive Breast Cancer and is currently completed. Centre hospitalier de l'Université de Montréal (CHUM) leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre hospitalier de l'Université de Montréal (CHUM)
Quebec Breast Cancer Foundation

Data source: Centre hospitalier de l'Université de Montréal (CHUM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada